Dopamine agonist withdrawal syndrome associated factors: A retrospective chart review

Related Articles:

• The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s.  It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
• The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
• Dopamine Agonist Withdrawal Syndrome (DAWS) in Parkinson’s January 8, 2018 “Some remedies are worse than the disease.” Publilius Syrus “Each patient carries his own doctor inside him.” Norman Cousins Summary: Dopamine agonists are widely used in the treatment of Parkinson’s, especially as a first-line therapy. Some patients on a dopamine agonist experience side-effects that require either tapering or discontinuation of the drug.  First described in 2010, dopamine agonist withdrawal syndrome…
• The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
• Dopamine agonist withdrawal syndrome associated factors: A retrospective chart review August 1, 2022 Clin Park Relat Disord. 2022 Jul 16;7:100153. doi: 10.1016/j.prdoa.2022.100153. eCollection 2022.ABSTRACTDopamine agonist withdrawal syndrome (DAWS) has been introduced to describe the constellation of symptoms resulting from reduction or suspension of dopamine agonist medications. In patients with Parkinson's disease (PD) the impact of DAWS can be significant in terms of distress and disability. Unfortunately, no standard treatment exists other than reintroduce…
• Dopamine agonist withdrawal syndrome associated factors: A retrospective chart review August 1, 2022 Clin Park Relat Disord. 2022 Jul 16;7:100153. doi: 10.1016/j.prdoa.2022.100153. eCollection 2022.ABSTRACTDopamine agonist withdrawal syndrome (DAWS) has been introduced to describe the constellation of symptoms resulting from reduction or suspension of dopamine agonist medications. In patients with Parkinson's disease (PD) the impact of DAWS can be significant in terms of distress and disability. Unfortunately, no standard treatment exists other than reintroduce…
• Dopamine agonist withdrawal syndrome associated factors: A retrospective chart review August 1, 2022 Clin Park Relat Disord. 2022 Jul 16;7:100153. doi: 10.1016/j.prdoa.2022.100153. eCollection 2022.ABSTRACTDopamine agonist withdrawal syndrome (DAWS) has been introduced to describe the constellation of symptoms resulting from reduction or suspension of dopamine agonist medications. In patients with Parkinson's disease (PD) the impact of DAWS can be significant in terms of distress and disability. Unfortunately, no standard treatment exists other than reintroduce…
• Dopamine agonist withdrawal syndrome associated factors: A retrospective chart review August 1, 2022 Clin Park Relat Disord. 2022 Jul 16;7:100153. doi: 10.1016/j.prdoa.2022.100153. eCollection 2022.ABSTRACTDopamine agonist withdrawal syndrome (DAWS) has been introduced to describe the constellation of symptoms resulting from reduction or suspension of dopamine agonist medications. In patients with Parkinson's disease (PD) the impact of DAWS can be significant in terms of distress and disability. Unfortunately, no standard treatment exists other than reintroduce…
• Part 1 of 2017 PWR! (Parkinson Wellness Recovery) Retreat: Pictures With Great Memories July 23, 2017 “Just put one foot in front of the other.”  Austin Peck “Coming together is a beginning; keeping together is progress; working together is success.”  Henry Ford Introduction to Part 1: From May 28-June 3, >100 people came to Scottsdale, Arizona for the PWR! Retreat. The final tally had >50 people-with-Parkinson’s, more than 30 care partners and ~20 physical therapists/fitness professionals,…
• Daily Inspiration (Mantra) from the 2018 PWR! (Parkinson Wellness Recovery) Retreat June 7, 2018 “One of the hardest things in life is having words in your heart that you can’t utter.” James Earl Jones “Good actions are a guard against the blows of adversity.” Abu Bakr Introduction:  A new part of the recently completed PWR! (Parkinson Wellness Recovery) retreat for 2018 in Scottsdale, AZ was something termed “Daily Inspiration or Daily Mantra”.  At the…
• Daily Inspiration (Mantra) from the 2018 PWR! (Parkinson Wellness Recovery) Retreat June 7, 2018 “One of the hardest things in life is having words in your heart that you can’t utter.” James Earl Jones “Good actions are a guard against the blows of adversity.” Abu Bakr Introduction:  A new part of the recently completed PWR! (Parkinson Wellness Recovery) retreat for 2018 in Scottsdale, AZ was something termed “Daily Inspiration or Daily Mantra”.  At the…
• Daily Inspiration (Mantra) from the 2018 PWR! (Parkinson Wellness Recovery) Retreat June 7, 2018 “One of the hardest things in life is having words in your heart that you can’t utter.” James Earl Jones “Good actions are a guard against the blows of adversity.” Abu Bakr Introduction:  A new part of the recently completed PWR! (Parkinson Wellness Recovery) retreat for 2018 in Scottsdale, AZ was something termed “Daily Inspiration or Daily Mantra”.  At the…
• 2019: Year in review December 31, 2019   In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2019. Month-by-month we will briefly discuss some of the major pieces of research/announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies to any researchers who…
• Phil Hesketh Event Raises Over $20,000 for Parkinson’s March 21, 2019 On the 28th of February over 140 people gathered at Manly Golf Club to hear Phil Hesketh talk on the Psychology of Pre – Suasion. Over three and a half hours Phil kept the crowd engaged and entertained on topics such as how to handle objections, the real meaning of ‘WIN-WIN’ and ‘Emotional Negotiation’.Shake It Up Board Member Graeme Fear and…
• Monthly Research Review – December 2020 December 31, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
• Monthy research review – December 2019 December 30, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Shining a light on Parkinson’s November 7, 2019   NOTE: The information in today’s post should not be considered an endorsement of PhotoPharmics or the treatment they are proposing. The author of this blog has had no communication with the company. The information in this post is provided because the author has been asked by readers to discuss it. In October 2018, at the annual International Movement Disorders…
• Monthly Research Review – July 2021 July 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during July 2021. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…
• Dopamine Agonists and Impulse Control Disorders in Parkinson’s July 4, 2018 “Whenever you are immersed in compulsive thinking, you are avoiding what is. You don’t want to be where you are. Here, Now.” Eckhart Tolle “Somewhere between obsession and compulsion is impulse.” Alexander Pushkin Introduction: In the latest issue of Neurology (June, 2018), Dr. Corvol and collaborators in Paris, France, present the results of a long-term study (5 years) on impulse…
• Dopamine Agonists and Impulse Control Disorders in Parkinson’s July 4, 2018 “Whenever you are immersed in compulsive thinking, you are avoiding what is. You don’t want to be where you are. Here, Now.” Eckhart Tolle “Somewhere between obsession and compulsion is impulse.” Alexander Pushkin Introduction: In the latest issue of Neurology (June, 2018), Dr. Corvol and collaborators in Paris, France, present the results of a long-term study (5 years) on impulse…
• Dopamine Agonists and Impulse Control Disorders in Parkinson’s July 4, 2018 “Whenever you are immersed in compulsive thinking, you are avoiding what is. You don’t want to be where you are. Here, Now.” Eckhart Tolle “Somewhere between obsession and compulsion is impulse.” Alexander Pushkin Introduction: In the latest issue of Neurology (June, 2018), Dr. Corvol and collaborators in Paris, France, present the results of a long-term study (5 years) on impulse…
• Year in review: 2021 December 31, 2021 # # # # As with the preceding year, 2021 proved to be challenging due to the continuing COVID-19 pandemic (and it is not over yet). Vaccines were rolled out with remarkable speed, but equally new variants of the virus popped up and have kept Governments and health regulatory bodies on their toes. An amazing feature of the last two…